Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012

S Schöpper; S Laban; B Güldenzoph; A Münscher; R Knecht; T Kurzweg

doi:10.1007/s00106-012-2596-9

Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms

Standard

Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms : Highlights vom ASCO-Kongress 2012. / Schöpper, S; Laban, S; Güldenzoph, B; Münscher, A; Knecht, R; Kurzweg, T.

In: HNO, Vol. 60, No. 11, 01.11.2012, p. 957-61.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schöpper, S, Laban, S, Güldenzoph, B, Münscher, A, Knecht, R & Kurzweg, T 2012, 'Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012', HNO, vol. 60, no. 11, pp. 957-61. https://doi.org/10.1007/s00106-012-2596-9

APA

Schöpper, S., Laban, S., Güldenzoph, B., Münscher, A., Knecht, R., & Kurzweg, T. (2012). Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012. HNO, 60(11), 957-61. https://doi.org/10.1007/s00106-012-2596-9

Vancouver

Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T. Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012. HNO. 2012 Nov 1;60(11):957-61. https://doi.org/10.1007/s00106-012-2596-9

Bibtex

@article{b7b955e746cb474d8fe6e1dcb336bd6c,

title = "Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms: Highlights vom ASCO-Kongress 2012",

abstract = "The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.",

keywords = "Carcinoma, Head and Neck Neoplasms, Humans, Lymphatic Metastasis, Medical Oncology, Neoplasm Recurrence, Local",

author = "S Sch{\"o}pper and S Laban and B G{\"u}ldenzoph and A M{\"u}nscher and R Knecht and T Kurzweg",

year = "2012",

month = nov,

day = "1",

doi = "10.1007/s00106-012-2596-9",

language = "Deutsch",

volume = "60",

pages = "957--61",

journal = "HNO",

issn = "0017-6192",

publisher = "Springer",

number = "11",

}

RIS

TY - JOUR

T1 - Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms

T2 - Highlights vom ASCO-Kongress 2012

AU - Schöpper, S

AU - Laban, S

AU - Güldenzoph, B

AU - Münscher, A

AU - Knecht, R

AU - Kurzweg, T

PY - 2012/11/1

Y1 - 2012/11/1

N2 - The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.

AB - The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.

KW - Carcinoma

KW - Head and Neck Neoplasms

KW - Humans

KW - Lymphatic Metastasis

KW - Medical Oncology

KW - Neoplasm Recurrence, Local

U2 - 10.1007/s00106-012-2596-9

DO - 10.1007/s00106-012-2596-9

M3 - SCORING: Zeitschriftenaufsatz

C2 - 23114541

VL - 60

SP - 957

EP - 961

JO - HNO

JF - HNO

SN - 0017-6192

IS - 11

ER -